BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30708237)

  • 1. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of overdose prevention sites during a public health emergency in Victoria, Canada.
    Pauly B; Wallace B; Pagan F; Phillips J; Wilson M; Hobbs H; Connolly J
    PLoS One; 2020; 15(5):e0229208. PubMed ID: 32438390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile supervised consumption services in Rural British Columbia: lessons learned.
    Mema SC; Frosst G; Bridgeman J; Drake H; Dolman C; Lappalainen L; Corneil T
    Harm Reduct J; 2019 Jan; 16(1):4. PubMed ID: 30634986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series.
    Panagiotoglou D
    PLoS One; 2022; 17(3):e0265665. PubMed ID: 35316284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
    Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
    Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G; Collins AB; McNeil R; Boyd J
    Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada.
    MacDougall L; Smolina K; Otterstatter M; Zhao B; Chong M; Godfrey D; Mussavi-Rizi A; Sutherland J; Kuo M; Kendall P
    PLoS One; 2019; 14(1):e0210129. PubMed ID: 30629607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
    Davidson PJ; Lopez AM; Kral AH
    Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California.
    Wenger LD; Morris T; Knight KR; Megerian CE; Davidson PJ; Suen LW; Majano V; Lambdin BH; Kral AH
    Int J Drug Policy; 2024 Apr; 126():104366. PubMed ID: 38492432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.
    Boyd J; Collins AB; Mayer S; Maher L; Kerr T; McNeil R
    Addiction; 2018 Dec; 113(12):2261-2270. PubMed ID: 30211453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing Use of Supervised Consumption Services among Street-involved Youth and Young Adults in the Context of an Overdose Crisis.
    Lee-Pii K; DeBeck K; Choi J; Sedgemore KO; Kerr T; Kennedy MC
    J Urban Health; 2024 Apr; 101(2):233-244. PubMed ID: 38536600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "We just don't have the space for it": Geographies of survival and spatial triage in overdose prevention sites.
    Olding M; Boyd J; Kerr T; McNeil R
    Health Place; 2023 Sep; 83():103067. PubMed ID: 37352615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada.
    Olding M; Boyd J; Kerr T; Fowler A; McNeil R
    Int J Drug Policy; 2023 Jan; 111():103929. PubMed ID: 36529032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.
    Collins AB; Boyd J; Mayer S; Fowler A; Kennedy MC; Bluthenthal RN; Kerr T; McNeil R
    Int J Drug Policy; 2019 Nov; 73():199-207. PubMed ID: 31542327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
    Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
    Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.